Results 301 to 310 of about 725,440 (353)

Correction to "Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice". [PDF]

ACS Pharmacol Transl Sci
Corvino A, Caliendo G, Fiorino F, Frecentese F, Valsecchi V, Lombardi G, Anzilotti S, Andreozzi G, Scognamiglio A, Sparaco R, Perissutti E, Severino B, Gargiulo M, Santagada V, Pignataro G.   +14 more
europepmc   +1 more source

Influence of <i>Fusobacterium nucleatum</i> on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis. [PDF]

Mediators Inflamm
Şenyüz B, Ünal NG, Yakut BD, Uzel A, Gündüz C, Süslüer SY.   +5 more
europepmc   +1 more source

Exploring the frequency of anemia in patients with Axial Spondyloarthritis: associations with inflammatory markers and response to Anti-Tumor Necrosis Factor (TNF)-α therapy. [PDF]

PeerJ
Güler D, Yilmaz E, Pasin Ö, Kılıçoğlu MS.   +3 more
europepmc   +1 more source

[Corrigendum] Tumor necrosis factor‑α triggers opposing signals in head and neck squamous cell carcinoma and induces apoptosis via mitochondrial‑ and non‑mitochondrial‑dependent pathways. [PDF]

Int J Oncol
Selimovic D, Wahl RU, Ruiz E, Aslam R, Flanagan TW, Hassan SY, Santourlidis S, Haikel Y, Friedlander P, Megahed M, Kandil E, Hassan M.   +11 more
europepmc   +1 more source

2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.

, 1989
H. Bielefeldt Ohmann, Marli Matiko Anraku de Campos, Philip Griebel, Lorne A. Babiuk   +3 more
openalex   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tumor Necrosis Factor

Scientific American, 1988
A century ago it was noted that a bacterial infection sometimes causes the regression of cancer. In 1975 the author found an explanation: the infection stimulates the secretion of tumor necrosis factor (TNF), which has anticancer activity. Now TNF, an important regulator of inflammation and immunity, is in clinical trials as an anticancer drug.
H F, Oettgen, L J, Old
openaire   +5 more sources

Tumor necrosis factors

Developmental & Comparative Immunology, 2004
Since the discovery of tumor necrosis factor (TNF) and lymphotoxin, many structurally related factors have been elucidated in mammals that are grouped together in the TNF Ligand Superfamily. These factors have profound pleiotropic roles involving inflammation, apoptosis, cell proliferation and stimulation of the immune system.
Frederick W, Goetz, Josep V, Planas, Simon, MacKenzie   +2 more
openaire   +2 more sources

Tumor Necrosis Factor and Anti-Tumor Necrosis Factor Therapies

The Journal of Rheumatology Supplement, 2010
Tumor necrosis factor (TNF) plays a crucial role in the pathogenesis of immune-mediated inflammatory diseases (IMID). As a result, the inhibition of TNF is an important therapeutic avenue in the treatment of these pathophysiologically diverse disease states.
Edward C, Keystone, Carl F, Ware
openaire   +2 more sources

Tumor necrosis factors in 1996

Cytokine & Growth Factor Reviews, 1996
The 6th International Congress on Tumor Necrosis Factors and Related Molecules was held in Faliraki, Island of Rhodes, Greece, 8-12 May, 1996. This review summarizes the topics addressed and highlights some of the major advances presented during the meeting.
K, Pfizenmaier, H, Wajant, M, Grell
openaire   +2 more sources